EPIRUS Biopharmaceuticals, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/16 Q1

ended 12/31/15 FY 2015 – amended

ended 12/31/15 FY 2015

Late annual filing notification for FY 2015

ended 09/30/15 Q3

Prospectuses and Registrations Filter

Commission order revoking registration

Removal from listing

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Camber Capital Management LP

Prudential Financial Inc.

Jennison Associates LLC

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Material Definitive Agreement, Termination of Material Definitive Agreement, Bankruptcy or Receivership, Change in Directors, Officers or Compensation, Other Events

Material Definitive Agreement, Termination of Material Definitive Agreement, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Change in Directors, Officers or Compensation, Other Events

Material Definitive Agreement, Other Events

Announces Reprioritization of Pipeline to Solely Focus on Biosimilars to Treat Rare Diseases and Key Leadership Changes

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Confidential treatment order